Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Yung, Mingo Ming Ho ^a   Chan, David Wai ^a   Liu, Vincent Wing Sun ^a   Yao, Kwok Ming ^a   Ngan, Hextan Yuen Sheung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

AMPK; Cervical cancer; FOXM1; FOXO3a

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; CALCIMYCIN; FOXM1 PROTEIN; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; METFORMIN; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; AMP-ACTIVATED PROTEIN KINASE KINASE; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, HUMAN; FOXO3 PROTEIN, HUMAN; PROTEIN KINASE;

ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HYPOXIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER; WESTERN BLOTTING; GENETIC TRANSFECTION; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

BLOTTING, WESTERN; CELL LINE, TUMOR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 84879812079     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-327     Document Type: Article

References (50)

1. Yang HJ, Liu VW, Tsang PC, Yip AM, Tam KF, Wong LC, Ng TY, Ngan HY. Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer. Int J Gynecol Cancer 2004, 14(5):903-910. 10.1111/j.1048-891X.2004.014528.x, 15361202.
2. Robinson-Bennett BL, Deford J, Diaz-Arrastia C, Levine L, Wang HQ, Hannigan EV, Papaconstantinou J. Implications of tyrosine phosphoproteomics in cervical carcinogenesis. J Carcinog 2008, 7:2. 10.1186/1477-3163-7-2, 2483982, 18637184.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
4. Nishio S, Katsumata N, Matsumoto K, Tanabe H, Yonemori K, Kohno T, Shimizu C, Ando M, Kasamatsu T, Fujiwara Y. Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma. Oncol Rep 2008, 19(2):497-503.
5. Witczak CA, Sharoff CG, Goodyear LJ. AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell Mol Life Sci 2008, 65(23):3737-3755. 10.1007/s00018-008-8244-6, 18810325.
6. Carling D. AMP-activated protein kinase: balancing the scales. Biochimie 2005, 87(1):87-91. 10.1016/j.biochi.2004.10.017, 15733742.
7. Hardie DG. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond) 2008, 32(Suppl 4):S7-S12.
8. Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 2009, 9(8):563-575. 10.1038/nrc2676, 2756045, 19629071.
9. Kuhajda FP. AMP-activated protein kinase and human cancer: cancer metabolism revisited. Int J Obes (Lond) 2008, 32(Suppl 4):S36-S41.
10. Yu SY, Chan DW, Liu VW, Ngan HY. Inhibition of cervical cancer cell growth through activation of upstream kinases of AMP-activated protein kinase. Tumour Biol 2009, 30(2):80-85. 10.1159/000216843, 19407487.
11. Fay JR, Steele V, Crowell JA. Energy homeostasis and cancer prevention: the AMP-activated protein kinase. Cancer Prev Res (Phila) 2009, 2(4):301-309.
12. Kwan HT, Chan DW, Cai PC, Mak CS, Yung MM, Leung TH, Wong OG, Cheung AN, Ngan HY. AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/beta-catenin signaling activity. PLoS One 2013, 8(1):e53597. 10.1371/journal.pone.0053597, 3534705, 23301094.
13. Wierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem 2007, 388(12):1257-1274.
14. Wang X, Kiyokawa H, Dennewitz MB, Costa RH. The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc Natl Acad Sci USA 2002, 99(26):16881-16886. 10.1073/pnas.252570299, 139238, 12482952.
15. Katoh M. Human FOX gene family (Review). Int J Oncol 2004, 25(5):1495-1500.
16. Kim IM, Ramakrishna S, Gusarova GA, Yoder HM, Costa RH, Kalinichenko VV. The forkhead box m1 transcription factor is essential for embryonic development of pulmonary vasculature. J Biol Chem 2005, 280(23):22278-22286. 10.1074/jbc.M500936200, 15817462.
17. Yoshida Y, Wang IC, Yoder HM, Davidson NO, Costa RH. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer. Gastroenterology 2007, 132(4):1420-1431. 10.1053/j.gastro.2007.01.036, 17408638.
18. Chan DW, Yu SY, Chiu PM, Yao KM, Liu VW, Cheung AN, Ngan HY. Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis. J Pathol 2008, 215(3):245-252. 10.1002/path.2355, 18464245.
19. Wilson MS, Brosens JJ, Schwenen HD, Lam EW. FOXO and FOXM1 in Cancer: The FOXO-FOXM1 Axis Shapes the Outcome of Cancer Chemotherapy. Curr Drug Targets 2011, 12(9):1256-1266. 10.2174/138945011796150244, 21443467.
20. Zhao F, Lam EW. Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance. Front Med 2012, 6(4):376-380. 10.1007/s11684-012-0228-0, 23124885.
21. Leung TW, Lin SS, Tsang AC, Tong CS, Ching JC, Leung WY, Gimlich R, Wong GG, Yao KM. Over-expression of FoxM1 stimulates cyclin B1 expression. FEBS Lett 2001, 507(1):59-66. 10.1016/S0014-5793(01)02915-5, 11682060.
22. Fung TK, Poon RY. A roller coaster ride with the mitotic cyclins. Semin Cell Dev Biol 2005, 16(3):335-342. 10.1016/j.semcdb.2005.02.014, 15840442.
23. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, Tan Y, Ackerson T, Costa RH. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 2005, 25(24):10875-10894. 10.1128/MCB.25.24.10875-10894.2005, 1316960, 16314512.
24. Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, Morrison A, Clevers H, Medema RH. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 2005, 7(2):126-136. 10.1038/ncb1217, 15654331.
25. Lok GT, Chan DW, Liu VW, Hui WW, Leung TH, Yao KM, Ngan HY. Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells. PLoS One 2011, 6(8):e23790. 10.1371/journal.pone.0023790, 3157468, 21858223.
26. Lam AK, Ngan AW, Leung MH, Kwok DC, Liu VW, Chan DW, Leung WY, Yao KM. FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c. Front Oncol 2013, 3:11. 3560383, 23386997.
27. Chan DW, Hui WW, Cai PC, Liu MX, Yung MM, Mak CS, Leung TH, Chan KK, Ngan HY. Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells. PLoS One 2012, 7(12):e52578. 10.1371/journal.pone.0052578, 3527599, 23285101.
28. Teh MT, Wong ST, Neill GW, Ghali LR, Philpott MP, Quinn AG. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res 2002, 62(16):4773-4780.
29. Madureira PA, Varshochi R, Constantinidou D, Francis RE, Coombes RC, Yao KM, Lam EW. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. J Biol Chem 2006, 281(35):25167-25176. 10.1074/jbc.M603906200, 16809346.
30. Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV, Major ML, Gusarova GA, Yoder HM, Costa RH, et al. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 2006, 66(4):2153-2161. 10.1158/0008-5472.CAN-05-3003, 16489016.
31. Douard R, Moutereau S, Pernet P, Chimingqi M, Allory Y, Manivet P, Conti M, Vaubourdolle M, Cugnenc PH, Loric S. Sonic Hedgehog-dependent proliferation in a series of patients with colorectal cancer. Surgery 2006, 139(5):665-670. 10.1016/j.surg.2005.10.012, 16701100.
32. Kalinichenko VV, Major ML, Wang X, Petrovic V, Kuechle J, Yoder HM, Dennewitz MB, Shin B, Datta A, Raychaudhuri P, et al. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev 2004, 18(7):830-850. 10.1101/gad.1200704, 387422, 15082532.
33. Ahmad A, Wang Z, Kong D, Ali S, Li Y, Banerjee S, Ali R, Sarkar FH. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Res Treat 2010, 122(2):337-346. 10.1007/s10549-009-0572-1, 19813088.
34. Kim YH, Liang H, Liu X, Lee JS, Cho JY, Cheong JH, Kim H, Li M, Downey TJ, Dyer MD, et al. AMPKalpha modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer. Cancer Res 2012, 72(10):2512-2521. 10.1158/0008-5472.CAN-11-3870, 22434430.
35. Guan TJ, Qin FJ, Du JH, Geng L, Zhang YY, Li M. AICAR inhibits proliferation and induced S-phase arrest, and promotes apoptosis in CaSki cells. Acta Pharmacol Sin 2007, 28(12):1984-1990. 10.1111/j.1745-7254.2007.00675.x, 18031613.
36. Din FV, Valanciute A, Houde VP, Zibrova D, Green KA, Sakamoto K, Alessi DR, Dunlop MG. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology 2012, 142(7):1504-1515. e1503, 10.1053/j.gastro.2012.02.050, 3682211, 22406476.
37. Karuman P, Gozani O, Odze RD, Zhou XC, Zhu H, Shaw R, Brien TP, Bozzuto CD, Ooi D, Cantley LC, et al. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell 2001, 7(6):1307-1319. 10.1016/S1097-2765(01)00258-1, 11430832.
38. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, Kondo S, Dumont DJ, Gutterman JU, Walker CL, et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 2007, 9(2):218-224. 10.1038/ncb1537, 17237771.
39. Short JD, Houston KD, Dere R, Cai SL, Kim J, Johnson CL, Broaddus RR, Shen J, Miyamoto S, Tamanoi F, et al. AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27. Cancer Res 2008, 68(16):6496-6506. 10.1158/0008-5472.CAN-07-5756, 3011867, 18701472.
40. Tiainen M, Vaahtomeri K, Ylikorkala A, Makela TP. Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1). Hum Mol Genet 2002, 11(13):1497-1504. 10.1093/hmg/11.13.1497, 12045203.
41. Zou Y, Tsai WB, Cheng CJ, Hsu C, Chung YM, Li PC, Lin SH, Hu MC. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis. Breast Cancer Res 2008, 10(1):R21. 10.1186/bcr1872, 2374977, 18312651.
42. Schmidt M, Fernandez de Mattos S, van der Horst A, Klompmaker R, Kops GJ, Lam EW, Burgering BM, Medema RH. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol 2002, 22(22):7842-7852. 10.1128/MCB.22.22.7842-7852.2002, 134724, 12391153.
43. Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007, 7(11):847-859. 10.1038/nrc2223, 17943136.
44. Fernandez De Mattos S, Villalonga P, Clardy J, Lam EW. FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells. Mol Cancer Ther 2008, 7(10):3237-3246. 10.1158/1535-7163.MCT-08-0398, 2748241, 18852127.
45. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96(6):857-868. 10.1016/S0092-8674(00)80595-4, 10102273.
46. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, Guarente L. Mammalian SIRT1 represses forkhead transcription factors. Cell 2004, 116(4):551-563. 10.1016/S0092-8674(04)00126-6, 14980222.
47. Chiacchiera F, Simone C. The AMPK-FoxO3A axis as a target for cancer treatment. Cell Cycle 2010, 9(6):1091-1096. 10.4161/cc.9.6.11035, 20190568.
48. Link W, Oyarzabal J, Serelde BG, Albarran MI, Rabal O, Cebria A, Alfonso P, Fominaya J, Renner O, Peregrina S, et al. Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases. J Biol Chem 2009, 284(41):28392-28400. 10.1074/jbc.M109.038984, 2788888, 19690175.
49. Rattan R, Giri S, Hartmann LC, Shridhar V. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. J Cell Mol Med 2011, 15(1):166-178. 10.1111/j.1582-4934.2009.00954.x, 19874425.
50. Li C, Liu VW, Chan DW, Yao KM, Ngan HY. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells. Int J Gynecol Cancer 2012, 22(1):15-22. 10.1097/IGC.0b013e3182322834, 22080879.